GB1135926A - Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives - Google Patents

Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives

Info

Publication number
GB1135926A
GB1135926A GB8166/66A GB816666A GB1135926A GB 1135926 A GB1135926 A GB 1135926A GB 8166/66 A GB8166/66 A GB 8166/66A GB 816666 A GB816666 A GB 816666A GB 1135926 A GB1135926 A GB 1135926A
Authority
GB
United Kingdom
Prior art keywords
hydroxypropylamine
phenyl
prepared
radicals
diphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8166/66A
Other languages
English (en)
Inventor
Roy Frederick Maisey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Priority to GB8166/66A priority Critical patent/GB1135926A/en
Priority to US615327A priority patent/US3422203A/en
Priority to BE694631D priority patent/BE694631A/xx
Priority to NL6702969A priority patent/NL6702969A/xx
Priority to FR96282A priority patent/FR7029M/fr
Publication of GB1135926A publication Critical patent/GB1135926A/en
Priority to MY7200110A priority patent/MY7200110A/xx
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB8166/66A 1965-03-01 1966-02-24 Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives Expired GB1135926A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB8166/66A GB1135926A (en) 1966-02-24 1966-02-24 Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives
US615327A US3422203A (en) 1966-02-24 1967-02-13 Treatment of depression with diphenyl prop-2-enylamine derivatives
BE694631D BE694631A (zh) 1966-02-24 1967-02-24
NL6702969A NL6702969A (zh) 1966-02-24 1967-02-24
FR96282A FR7029M (zh) 1965-03-01 1967-05-22
MY7200110A MY7200110A (en) 1966-02-24 1972-12-31 Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB460766 1966-02-24
GB8166/66A GB1135926A (en) 1966-02-24 1966-02-24 Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives
GB2627566 1966-06-13
GB4607266 1966-10-14

Publications (1)

Publication Number Publication Date
GB1135926A true GB1135926A (en) 1968-12-11

Family

ID=27447388

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8166/66A Expired GB1135926A (en) 1965-03-01 1966-02-24 Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives

Country Status (5)

Country Link
US (1) US3422203A (zh)
BE (1) BE694631A (zh)
FR (1) FR7029M (zh)
GB (1) GB1135926A (zh)
NL (1) NL6702969A (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6051610A (en) * 1993-02-08 2000-04-18 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA525752A (en) * 1956-06-05 V. Petersen Poul Antispasmodic unsaturated tertiary amines
DE1122514B (de) * 1959-09-08 1962-01-25 Giulini Gmbh Geb Verfahren zur Herstellung von blutdrucksteigerndem 2-AEthyl-3,3-diphenyl-propen-(2)-yl-amin
DE1203247B (de) * 1961-10-10 1965-10-21 Koninklijke Pharma Fab Nv Verfahren zur Herstellung von Diphenylalkenyl-aminen sowie deren nicht-toxischen Salzen
DE1149002B (de) * 1961-10-19 1963-05-22 Giulini Gmbh Geb Verfahren zur Herstellung von blutdrucksteigernden Salzen von N, N-Dialkyl-2-aethyl-3, 3-diphenyl-propen-(2)-yl-aminen

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6051610A (en) * 1993-02-08 2000-04-18 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7268166B2 (en) 1993-02-08 2007-09-11 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases

Also Published As

Publication number Publication date
BE694631A (zh) 1967-08-24
US3422203A (en) 1969-01-14
NL6702969A (zh) 1967-08-25
FR7029M (zh) 1969-06-09

Similar Documents

Publication Publication Date Title
GB1163324A (zh)
GB1374979A (en) 3,5-dioxopiperazine derivatives
GB1231311A (zh)
GB1327227A (en) Pharmaceutical compositions containing phthalic or quinoline and derivatives
GB1135926A (en) Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives
GB1216945A (en) Novel imidazoline derivatives, the preparation thereof and compositions containing the same
GB1475314A (en) Phenyl-propylamine derivatives
GB1134715A (en) Bisphenylalkenylamine derivatives
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
GB1208195A (en) Process for producing benzodiazepine derivatives
GB1359171A (en) Azo dye-stuffs their manufacture and use
GB1301347A (zh)
GB1160064A (en) Indole Derivatives
GB1252937A (zh)
ES330304A1 (es) Procedimiento para la preparacion de derivados de la isoquinolina.
GB1219176A (en) Antihypertensive compositions and their preparation
GB1367678A (en) Substituted phenyl aminoethanols
GB1467528A (en) Piperazinium 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolyl acetate
GB1398683A (en) Process for the production of 2-hydroxy-4-alkoxy-benzophenones
GB1229574A (zh)
ES312318A1 (es) Procedimiento para la preparacion de hidrazinas de 1 amino-4-dibenzocicloheptenilpiperazinas.
GB1235957A (en) Alkaloid derivative
GB1344655A (en) Diphenylmethyl aminopropyl ethers
GB1253548A (en) Improvements in or relating to benzylideneamino guanidine derivatives
ES381207A1 (es) Un procedimiento para preparar nuevas 1,2-difenil-3,5-dioxo-pirazolidinas sustituidas en la posicion 4.